- ALBO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Albireo Pharma (ALBO) S-3Shelf registration
Filed: 22 Dec 16, 12:00am
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (Form S-3) and related Prospectus of Albireo Pharma Inc. (formerly Biodel Inc.) for the registration of common stock, preferred stock, debt securities, and warrants and to the incorporation by reference therein of our report dated July 13, 2016, with respect to the consolidated financial statements of Albireo Ltd. for the years ended December 31, 2014 and 2015, included in the Proxy Statement of Albireo Pharma Inc. (formerly Biodel Inc.) (Schedule 14A dated 09-19-2016) and incorporated by reference through the Form 8-K, filed on November 4, 2016 with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
Reading, England
December 22, 2016
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.